A Phase I Dose Escalation Study of Peptide Vaccines With Activity Against Human Cytomegalovirus.
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Agatolimod (Primary) ; Cytomegalovirus vaccines (Primary)
- Indications Cytomegalic inclusion disorders; Cytomegalovirus infections
- Focus Adverse reactions
- 22 Jun 2012 Actual patient number 68 added as reported by ClinicalTrials.gov.
- 22 Jun 2012 Actual end date (1 Apr 2012) added as reported by ClinicalTrials.gov.
- 22 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.